Peptide record

TPDB11685

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11685
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP Peptipedia Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 37-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GLLSVLKGVLKTTGKHIFKNVGGSLLDQAKCKISGQC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C170H294N48O48S2
REMPWY
GLK
3842.62
10.27
7
1
13
+5
0.41
0.195
110.54
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.03
10
Residue Composition
number
1
A
0
R
1
N
1
D
2
C
0
E
2
Q
6
G
1
H
2
I
6
L
6
K
0
M
1
F
0
P
3
S
2
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 1 R: 0 N: 1 D: 1 C: 2 E: 0 Q: 2 G: 6 H: 1 I: 2 L: 6 K: 6 M: 0 F: 1 P: 0 S: 3 T: 2 W: 0 Y: 0 V: 3
Chemical Descriptors
37 reviewed residue count
C170H294N48O48S2 sequence-only estimate (linear, free termini)
3842.62 sequence-only estimate (linear, free termini)
10.27 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
0.41 sequence-only estimate (linear, free termini)
0.195 sequence-only estimate (linear, free termini)
Evidence Records 26 records
Evidence 1 Activity

Activity

MIC
Antibacterial
3 µM

Target

Escherichia coli

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MI
Evidence 2 Activity

Activity

MIC
Antibacterial
3 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (
Evidence 3 Activity

Activity

MIC
Antibacterial
3 µM

Target

Enterobacter cloacae

Source & Reference

dbAMP

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM
Evidence 4 Activity

Activity

MIC
Antibacterial
6 µM

Target

Klebsiella pneumoniae

Source & Reference

dbAMP

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 5 Activity

Activity

MIC
Antibacterial
25 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

li (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 6 Activity

Activity

MIC
Antibacterial
>100 µM

Target

C.albicans

Source & Reference

dbAMP

Other

a (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 7 Activity

Activity

MIC
Antifungal
3 µM

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MI
Evidence 8 Activity

Activity

MIC
Antifungal
3 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (
Evidence 9 Activity

Activity

MIC
Antifungal
3 µM

Target

Enterobacter cloacae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM
Evidence 10 Activity

Activity

MIC
Antifungal
6 µM

Target

Klebsiella pneumoniae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 11 Activity

Activity

MIC
Antifungal
25 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

li (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 12 Activity

Activity

MIC
Antifungal
>100 µM

Target

C.albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

a (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 13 Activity

Activity

MIC
Antiparasitic
3 µM

Target

Escherichia coli

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MI
Evidence 14 Activity

Activity

MIC
Antiparasitic
3 µM

Target

Pseudomonas aeruginosa

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (
Evidence 15 Activity

Activity

MIC
Antiparasitic
3 µM

Target

Enterobacter cloacae

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM
Evidence 16 Activity

Activity

MIC
Antiparasitic
6 µM

Target

Klebsiella pneumoniae

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 17 Activity

Activity

MIC
Antiparasitic
25 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

li (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 18 Activity

Activity

MIC
Antiparasitic
>100 µM

Target

C.albicans

Source & Reference

NA

Other

a (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 19 Activity

Activity

MIC
Antiviral
3 µM

Target

Escherichia coli

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MI
Evidence 20 Activity

Activity

MIC
Antiviral
3 µM

Target

Pseudomonas aeruginosa

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (
Evidence 21 Activity

Activity

MIC
Antiviral
3 µM

Target

Enterobacter cloacae

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM
Evidence 22 Activity

Activity

MIC
Antiviral
6 µM

Target

Klebsiella pneumoniae

Source & Reference

NA

Other

Active against E. coli (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 23 Activity

Activity

MIC
Antiviral
25 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

li (MIC 3 uM), P. aeruginosa (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 24 Activity

Activity

MIC
Antiviral
>100 µM

Target

C.albicans

Source & Reference

NA

Other

a (MIC 3 uM), E. cloacae (MIC 3 uM), K. pneumoniae (MIC 6 uM), S. aureus (MIC 25 uM), and C.albicans (MIC>100 uM). HC50 80 uM. Updated 11/2019 7/2021
Evidence 25 Activity

Activity

50% Hemolysis
Toxicity
80 µM
Hemolytic Cytotoxic
50% Hemolysis | 80 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. | Regul Pept | 2004
Evidence 26 Hemolysis

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.